SCHEMBL7149449

SCHEMBL7149449

CC1(CCC(O)c2ccc(Oc3ccc(Cl)cn3)cc2)NC(=O)NC1=O

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 7/20 0.42
ADAMTS5 Q9UNA0 6/20 0.42
MMP2 P08253 3/20 0.42
MMP12 P39900 2/20 0.42
ADAMTS4 O75173 1/20 0.42
MMP3 P08254 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
LIPE Q05469 1/20 0.38
SCN9A Q15858 3/20 0.36
LTA4H P09960 1/20 0.35
HRH3 Q9Y5N1 1/20 0.34
FPR2 P25090 1/20 0.34
P2RX3 P56373 1/20 0.34
ADAM17 P78536 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6787629 0.80 LIPE (0.41) MMP13ADAMTS5MMP2MMP12ADAMTS4
SCHEMBL942365 0.76 MMP13 (0.45) MMP13ADAMTS5MMP2MMP12ADAMTS4
SCHEMBL6787131 0.76 CYP3A4 (0.41) LIPESCN9AP2RX3
SCHEMBL1108546 0.67 PTGS1 (0.41) MMP13ADAMTS5MMP2MMP12ADAMTS4
SCHEMBL1108576 0.67 PTGS1 (0.41) MMP13ADAMTS5MMP2MMP12ADAMTS4
SCHEMBL17487850 0.65 ADRB2 (0.52) LIPESCN9ALTA4HHRH3FPR2
SCHEMBL6878178 0.65 MMP13 (0.58) MMP13ADAMTS5MMP2MMP12ADAMTS4
SCHEMBL6791426 0.65 ACACB (0.46) LIPESCN9ALTA4H
SCHEMBL8683717 0.64 LIPE (0.54) SMN1; SMN2NPSR1LIPESCN9ALTA4H
SCHEMBL8684262 0.63 LIPE (0.51) SMN1; SMN2LIPESCN9ALTA4HHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1370536-A1 METALLOPROTEINASE INHIBITORS AstraZeneca AB (SE) 2003-12-17 EP disclosed
WO-2002074750-A1 METALLOPROTEINASE INHIBITORS ASTRAZENECA AB (SE) 2002-09-26 WO disclosed